In re Cellect Poses an Obvious Dilemma

Published date07 May 2024
Subject MatterUSPTO,Patents,Obviousness,Patent Term Adjustment,Patent Terms,Patent Litigation,Pharmaceutical Patents,Patent Infringement,Intellectual Property Protection,Pharmaceutical Industry,Obviousness-Type Double Patenting (ODP)
AuthorSommer Zimmerman, JD, PhD
Law FirmBallard Spahr LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT